Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin irritation / corrosion

Currently viewing:

Administrative data

Endpoint:
skin irritation: in vitro / ex vivo
Type of information:
migrated information: read-across from supporting substance (structural analogue or surrogate)
Adequacy of study:
key study
Study period:
2011
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: GLP study conducted without any deviations to the guideline, but quoted with 2 because of the read across

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2011
Report date:
2011

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
Deviations:
no
Qualifier:
according to guideline
Guideline:
EU Method B.46 (In Vitro Skin Irritation: Reconstructed Human Epidermis Model Test)
Deviations:
no
GLP compliance:
yes (incl. QA statement)

Test material

Constituent 1
Reference substance name:
Hafnium dioxide
EC Number:
235-013-2
EC Name:
Hafnium dioxide
IUPAC Name:
hafnium dioxide
Test material form:
solid: crystalline

Test animals

Species:
other: in vitro test using human skin model
Details on test animals or test system and environmental conditions:
not applicable

Test system

Vehicle:
water
Amount / concentration applied:
TEST MATERIAL
- Amount(s) applied: 10 mg (26.3 mg/cm²) of the crushed powder were applied to the epidermis surface

VEHICLE: 5µL distilled water were used as vehicle
Details on study design:
The study was carried out with the Episkin SM tissues provided as a kit.
The tissues were exposed to the substance during 15 minutes and then post incubated 42h. The viability was determined by optical densimetry at 550nm to check the colouring potential of the substance (= reduction of MTT).

Results and discussion

In vitro

Results
Irritation / corrosion parameter:
other: other: MTT reduction showed by optical density
Value:
98.4
Remarks on result:
other:
Remarks:
Basis: other: mean tissue viability. Reversibility: other: not applicable. (migrated information)

In vivo

Irritant / corrosive response data:
The mean relative tissues viability is ≥ 50% and then substance showed no irritant effects.

Any other information on results incl. tables

table of results:

 

Negative control : PBS

Positive control : SDS 5%

HfO2

Blank corrected mean OD at 550nm

0.847

0.883

0.859

0.049

0.055

0.070

0.892

0.816

0.838

Blank corrected mean OD of the 3 replicates

0.863

0.058

0.849

Standard deviation OD

0.02

0.01

0.04

Relative tissue viabilities %

98.1

102.4

99.5

5.7

6.3

8.1

103.4

94.6

97.1

Mean tissue viabilities %

100

6.7

98.4

Standard deviation tissue viabilities %

2.2

1.3

4.6

Applicant's summary and conclusion

Interpretation of results:
not irritating
Remarks:
Migrated information Criteria used for interpretation of results: other: UN GHS and EU CLP
Executive summary:

The potential of the test item to induce skin irritation was tested by using the three dimensional human skin model Episkin-SM. HfO2 was applied with water topically to the tissue for 15 minutes followed by a 42h post incubation period and immediate determination of cytotoxic effects via MTT reduction assay.

Irritant potential was predicted from the relative mean tissue viabilities obtained compared to the negative control treated with PBS.

HfO2 showed no irritant effects as the mean relative tissue viability was ≥ 50% (98.4%).

The controls confirmed the validity of the study:

- the mean optical density of the six blank values was < 0.1

- the mean absolute OD of the three negative control tissues was ≥0.6 and ≤ 1.5

- the mean relative tissue viability of the positive control (SDS 5%) was ≤ 40% (6.7%)

- the maximum standard deviation of viability of replicate tissues of all dose groups was ≤ 18% (1.3 - 4.5%).